3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
4
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Specimen Handling
6
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Platinum
3
Cisplatin
3
Cetuximab
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
Radiotherapy, Intensity-Modulated
2
Immunoglobulin G
2
Disulfides
2
merphos
1
durvalumab
1
cabozantinib
1
atezolizumab
1
X-Rays
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Nivolumab
1
Methotrexate
1
Interviews as Topic
1
Erlotinib Hydrochloride
1
Docetaxel
1
Celecoxib
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
Early Intervention, Educational
×
30 days
×
Clear all
No trials found.